Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0348406 Subunit Immersion Vaccines for Fish
The present disclosure provides an immersion vaccine for fish comprising at least one isolated antigen, specifically a recombinant antigen, such as is F....
2017/0348405 MODIFICATION OF RECOMBINANT ADENOVIRUS WITH IMMUNOGENIC PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES
The present disclosure relates to adenovirus protein modifications to augment immune response to a transgene of a recombinant adenovirus and to circumvent...
2017/0348404 VACCINATION METHODS
In one aspect, a method of treating cancer in a mammal is provided. The method comprises administering to the mammal an oncolytic vector that expresses a...
2017/0348403 ADHERENT CANCER CELL LINE EXPRESSING A HEMATOLOGICAL TUMOR ANTIGEN
The present invention relates to a transduced cancer cell line stably expressing a leukemia tumor antigen, wherein the cancer cell line is cervical cancer...
2017/0348402 SYSTEM AND METHOD FOR DELIVERING GENETIC MATERIAL OR PROTEIN TO CELLS
It has been established that bacterial hybrid vectors including prokaryote cells modified by the addition of cationic polymers to the outer surface of the cell...
2017/0348401 GAS-FILLED MICROVESICLES FOR USE AS VACCINE
Gas-filled microvesicles comprising an antigen bound thereto and to aqueous suspensions containing said microvesicles, for use in immunomodulating...
2017/0348400 METHODS AND COMPOSITIONS FOR ENHANCING AN IMMUNE RESPONSE, BLOCKING MONOCYTE MIGRATION, AMPLIFYING VACCINE...
Provided are methods of enhancing an immune response and methods for reducing the recruitment of monocytes to a lymph node by administering to an individual an...
2017/0348399 NOVEL PROTEIN MATERIAL
The invention relates to a protein material includes angiogenin and/or angiogenin hydrolysate in an amount of 2 to 15 mg/100 mg, and lactoperoxidase and/or...
2017/0348398 COMPOSITIONS AND METHODS FOR DECREASING BLOOD GLUCAGON LEVELS
Disclosed are improved compositions and methods for decreasing blood glucagon levels. As disclosed herein, L-glutamine is a selective stimulator of...
2017/0348397 Serum Albumin-Binding Fibronectin Type III Domains
Fibronectin type III domains (FN3) that specifically bind to serum albumin, related polynucleotides capable of encoding serum albumin-specific FN3 domains,...
2017/0348396 Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial...
A physically stable compositions in the form of an injectable aqueous solution, the pH of which is from 6.0 to 8.0: a basal insulin of which the isoelectric...
2017/0348395 Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
An injectable aqueous solution, the pH of which is from 6.0 to 8.0, having at least: a) human glucagon, and b) a co-polyamino acid bearing carboxylate charges...
2017/0348394 COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A STATISTICAL...
Physically stable compositions in the form of an injectable aqueous solution, the pH of which is from 6.0 to 8.0, includes at least: a) human glucagon, and b)...
2017/0348393 TREATMENT OF CNS INFLAMMATORY DISORDERS
A method of upregulating an anti-inflammatory response in a central nervous system (CNS) of a subject in need thereof is disclosed. The method comprising...
2017/0348392 SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at...
2017/0348391 MULTIPLE-VARIABLE IL-2 DOSE REGIMEN FOR TREATING IMMUNE DISORDERS
The present invention is based, in part, on the identification of iiicihods of using multiple-variable IL-2 doses for identifying, assessing, preventing, and...
2017/0348390 COMPOSITIONS AND METHODS FOR TREATING CANCER
Cancer is a complex group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Described herein are...
2017/0348389 TREATING LIVER DISEASES WITH INTERLEUKIN 24
Methods of treating liver diseases such as liver fibrosis using an interleukin 24 (IL-24) protein.
2017/0348388 ADJUVANTS USEFUL FOR STIMULATION OF IMMUNITY TO TUMOR ENDOTHELIAL CELLS
Adjuvants acting at the level of antigen presentation useful for stimulation of specific immunity against tumor endothelial cells. In one embodiment the...
2017/0348387 AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY
Described herein are methods of preventing, arresting progression of or ameliorating vision loss and other conditions associated with Leber congenital...
2017/0348386 METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
The present disclosure provides targeting peptides and vectors containing a sequence that encodes targeting peptides that deliver agents to the brain.
2017/0348385 GLYCOPEPTIDE COMPOSITIONS
Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or ...
2017/0348384 Treatment of Rhinosinusitis with P-glycoprotein Inhibitors
Provided herein are, inter alia, methods for treating rhinosinusitis with P-glycoprotein inhibitors. A subject having rhinosinusitis is identified and then...
2017/0348383 NOVEL COMBINATION AND USE
The present invention relates to the use of one or more compounds selected from the following: caffeic acid, thymol, aspirin, benzydamine hydrochloride,...
2017/0348382 LYOPHILIZED INJECTABLE COMPOSITIONS OF DAPTOMYCIN
The present invention relates to lyophilized compositions comprising daptomycin or pharmaceutically acceptable salts or solvates thereof with improved...
2017/0348381 FORMULATION
The present disclosure relates to an aqueous composition of an antifungal peptide, to methods of treatment using the composition and to uses of the composition.
2017/0348380 INTRAARTICULAR APPLICATION OF PEPSTATIN IN THE CASE OF ARTHROSIS
The present invention relates to pharmaceutical preparations and medicaments for intraarticular administration, comprising pepstatin, and to the preparation...
2017/0348379 METHODS AND SYSTEMS FOR DELIVERY OF ZW1 HEPTAPEPTIDE
The present invention generally relates to systems and methods for the transdermal delivery of the heptapeptide ZW1. In some aspects, ZW1 may be contained with...
2017/0348378 METHODS OF TREATING LUNG INFECTION WITH CASPOFUNGIN
Methods for the treatment and/or prevention of a fungal infection in the pulmonary system of a subject in need thereof with caspofungin or a derivative thereof...
2017/0348377 COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING
The invention relates to methods for modulating the immune function through targeting of CLIP molecules. The result is wide range of new therapeutic regimens...
2017/0348376 TUBULYSIN CONJUGATE FOR USE IN TREATING CANCER
The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating folate...
2017/0348375 DISLODGEMENT AND RELEASE OF HSC FROM THE BONE MARROW STEM CELL NICHE USING ALPHA9 INTEGRIN ANTAGONISTS
Haematopoietic stem cell mobilization is a process whereby haematopoietic stem cells are stimulated out of the bone marrow space. Before HSC can mobilize, they...
2017/0348374 ANTI CANCEROUS, ANTIPARASITE (TOXOPLASMA GONDII (PROTOZON) AND ANTIMICROBIAL EFFECT AND DOSAGE OF GINGER...
It has been discovered that the formulation of Ginger (Zingiber officinale) together with solvents had antineoplastic efficiency on cancerous cells. This...
2017/0348373 COMPOSITION COMPRISING CAFFEOYLSHIKIMIC ACIDS, PROTOCATECHUIC ACID, HYDROXYTYROSOL, HYDROXYBENZOIC ACID AND...
A composition comprising caffeoylshikimic acids, protocatechuic acid, hydroxytyrosol, hydroxybenzoic acid, caffeoylshikimic acids and their derivatives...
2017/0348372 ACNE-REMOVING TRADITIONAL CHINESE MEDICINE COMPOSITION AND PREPARATION METHOD THEREOF
Disclosed are an acne-removing traditional Chinese medicine composition and a preparation method thereof, wherein the traditional Chinese medicine composition...
2017/0348371 THE ANTI CANCEROUS, ANTIPARASITE (TOXOPLASMA GONDII (PROTOZOON) AND ANTIMICROBIAL EFFECT AND DOSAGE OF NIGELLA...
It has been discovered that the formulation of Nigella Sativa together with solvents had antineoplastic efficiency on cancerous cells. This formulation has...
2017/0348370 SOYBEAM SEED EXTRACT, METHOD FOR PRODUCING THE SAME AND USES THEREOF
The invention relates to a soybean seed extract, method for producing the same and uses of the extract of soybean seeds in promoting wound healing, promoting...
2017/0348369 Plant Extract and Its Therapeutic Use
The present invention is directed to a composition comprising an aqueous and/or organic extract of at least one Chamomilla plant and/or of at least one...
2017/0348368 Medicinal Composition of Extract of Seed of Emblica Officinalis and Method of Preparing the Same
A composition having an extract of seed of Emblica officinalis. Methods of preparing extract of seed of Emblica officinalis. An amla seed blend composition...
2017/0348367 USE OF HELMINTHOSTACHYS ZEYLANICA, UGONINS OR FLAVONE-BASED COMPOUNDS FOR THE TREATMENT OR PREVENTION OF...
Disclosed is a use of Helminthostachys zeylanica, ugonins or compounds of formula (I) for the treatment or prevention of metabolic diseases comprising at least...
2017/0348366 METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME
There is a disclosed a method of killing abnormal cells such as malignant cells including melanoma cells, using a virus recognising at least one of a cell...
2017/0348365 NOVEL ENTEROPATHOGENIC E. COLI BACTERIOPHAGE ESC-CHP-2 AND USE THEREOF FOR INHIBITING PROLIFERATION OF...
The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli...
2017/0348364 PROCESS FOR THE MANUFACTURE OF PATHOGEN INHIBITING BACTERIA
Processes to produce microorganisms that can be incorporated into a microbial-based product that results in high viable cell yields and shelf-stable products...
2017/0348363 IMMUNE MODULATION FOR ISCHEMIA DISEASE AND ACCELERATION OF RECOVERY AFTER ISCHEMIC EVENTS BY MICROBIOME...
Disclosed are compositions of matter treatment protocols and combination therapies aimed at stimulating neoangiogensis in ischemia tissue and means of...
2017/0348362 ANTHELMINTIC PROBIOTIC COMPOSITIONS AND METHODS
Compositions and methods for treating or reducing the severity or likelihood of occurrence of a parasitic worm or helminth infection in a subject are...
2017/0348361 PROBIOTIC AUGMENTATION OF ANTI-TUMOR ENDOTHELIUM IMMUNE RESPONSES
Augmenting or stimulating an immune response, to tumor endothelial cells, by: a) obtaining a tumor endothelial antigen or composition of antigens; b)...
2017/0348360 Compositions and Methods for Treating Inflammatory Bowel Diseases (IBDs) and Other Disorders
The present disclosure is in the field of pharmaceutical compositions suitable for the treatment of diseases in mammals. This application provides novel...
2017/0348359 Method and System for Treating Cancer and Other Age-Related Diseases by Extending the Healthspan of a Human
Various embodiments of the present invention are directed to the field of Oncology, and in particular, embodiments directed to a method of ameliorating,...
2017/0348358 Compositions and Methods for the Treatment of Hepatic Diseases and Disorders
The disclosure provides oral compositions and methods of using such compositions in treating subjects infected with one or more hepatic disorders. The...
2017/0348357 TAU PROTEIN PRODUCTION ACCELERATOR, AND THERAPEUTIC OR PREVENTIVE AGENT AND THERAPEUTIC OR PREVENTIVE FOOD...
An object of the present invention is to provide: a Tau protein production accelerator containing a natural product as an active ingredient; a therapeutic or...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.